Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients

被引：0
|
作者：
Farinella, Joseph [1 ]
Granat, Lauren M. [2 ]
Li, Hong [3 ]
Caroniti, Sharon M. [1 ]
Hegde, Pranay S. [4 ]
Kalaycio, Matt [5 ]
Sobecks, Ronald [6 ]
Brunstein, Claudio [5 ]
Sauter, Craig S. [5 ]
Hamilton, Betty K. [7 ]
机构：
[1] Cleveland Clin, Blood & Marrow Transplant, Cleveland, OH 44106 USA
[2] Cleveland Clin, Internal Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Biostat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] NHLBI, Lab Myeloid Malignancies, Hematol Branch, Cleveland, OH USA
[5] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
[6] Cleveland Clin, Blood & Marrow Transplant Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant
    Hegde, Pranay S.
    Rybicki, Lisa
    Serafino, Sheila
    Bernhard, Laura
    Corrigan, Donna
    Anwer, Faiz
    Kalaycio, Matt
    Sobecks, Ronald M.
    Jagadeesh, Deepa
    Hill, Brian T.
    Dean, Robert M.
    Khouri, Jack
    Winter, Allison M.
    Pohlman, Brad
    Majhail, Navneet S.
    Hamilton, Betty K.
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1031 - 1033
  • [32] Day+30 and Day+100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis
    Jain, Tania
    Temkit, M'hamed
    Partain, Daniel K.
    Patnaik, Mrinal M.
    Slack, James L.
    Khera, Nandita
    Hogan, William J.
    Roy, Vivek
    Noel, Pierre
    Leis, Jose F.
    Sproat, Lisa
    Fauble, Veena D. S.
    Mesa, Ruben A.
    Palmer, Jeanne
    BLOOD, 2016, 128 (22)
  • [33] Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Kamitani, Iku
    Yokoyama, Hiroki
    Ishii, Hiroto
    Tanoue, Susumu
    Hattori, Daiki
    Saito, Takeshi
    Yano, Shingo
    BLOOD, 2023, 142
  • [34] Pediatric Hematopoietic Stem Cell Transplant Patients' Six-Minute Walk Test Distance Declines at Day 100 but Returns to Baseline by 1-Year Post Transplant
    Towe, C.
    Chhabra, A.
    Gloude, N. J.
    Foster, K.
    Walkup, L.
    Woods, J. C.
    Mount, L.
    Grimley, M. S.
    Davies, S. M.
    Myers, K. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [35] Pre- Transplant Ferritin Predicts Overall Survival and Non-Relapse Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis
    Andrade-Gonzalez, Xavier A.
    Tefferi, Ayalew
    Pardanani, Animesh
    Gangat, Naseema
    Patnaik, Mrinal M.
    Palmer, Jeanne M.
    Kharfan-Dabaja, Mohamed A.
    Litzow, Mark
    Shah, Mithun Vinod
    Hogan, William J.
    Alkhateeb, Hassan B.
    BLOOD, 2020, 136
  • [36] Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients
    Wojenski, D. J.
    Bartoo, G. T.
    Merten, J. A.
    Dierkhising, R. A.
    Barajas, M. R.
    el-Azhary, R. A.
    Wilson, J. W.
    Plevak, M. F.
    Hogan, W. J.
    Litzow, M. R.
    Patnaik, M. M.
    Wolf, R. C.
    Hashmi, S. K.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) : 250 - 258
  • [37] Voriconazole Exposure and the Risk of Cutaneous Squamous Cell Carcinoma in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Hashmi, Shahrukh
    Wojenski, Daniel
    Merten, Julianna
    Wolf, Robert
    Bartoo, Gabriel
    Wilson, John
    El-azhary, Rokea
    Dierkhising, Ross
    Patnaik, Mrinal
    Hogan, William
    Litzow, Mark R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S227 - S228
  • [38] Voriconazole Exposure and The Risk Of Cutaneous Squamous Cell Carcinoma In Allogeneic Hematopoietic Stem Cell Transplant Patients
    Hashmi, Shahrukh K.
    Wojenski, Daniel
    Bartoo, Gabriel
    Merten, Julianna A.
    Dierkhising, Ross
    Elazhary, Rokea
    Wilson, John W.
    Wolf, Robert
    Patnaik, Mrinal M.
    Hogan, William
    Litzow, Mark R.
    BLOOD, 2013, 122 (21)
  • [39] EBMT SCORE ONLY PREDICTS DAY 100 OVERALL SURVIVAL AND OVERALL SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS
    Takeuchi, S.
    Nakano, N.
    Kubota, A.
    Tokunaga, M.
    Takatsuka, Y.
    Utsunomiya, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S181 - S181
  • [40] The incidence of catheter-related infections from day 0 to day 100 in allogeneic stem cell transplant patients
    Berthelsen, A
    Laursen, H
    Lanther, T
    Holder, J
    Rasmussen, S
    Heilmann, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S265 - S265
12345